Further analysis of clinical features revealed a negative correlation between the expression of TGFβ1 and the survival time of gastric adenocarcinoma patients, and a high correlation between TGFβ1 and T staging. This evidence concerns the gene TGFB1 and gastric adenocarcinoma.